Genetic Variants Linked to Antidepressant Response

Researchers at the University of Bologna in Italy have made a breakthrough in understanding the genetic factors contributing to variability in antidepressant response. By examining a panel of markers in the 5-HT1A gene, they identified three variants - rs10042486C/T, rs1364043T/G, and a combination of rs10042486-rs6295-rs1364043 - that are significantly associated with better antidepressant response in Japanese patients with major depressive disorder.

Key Takeaways:

  • The study found a significant association between the rs10042486C/T variant and improved antidepressant response in 137 Japanese patients with major depressive disorder.
  • The researchers observed a strong linkage disequilibrium between the rs10042486C/G, rs6295C/G, and rs1364043T/G variants, suggesting that functional effects could be associated with polymorphisms other than or together with the synonymous rs6295C/G.
  • The study highlights the importance of genetic factors in influencing antidepressant response and suggests that the HTR1A gene could be a potential target for the development of personalized therapies.
  • The finding adds new information to the understanding of the genetics of antidepressant response and provides a basis for further study in larger samples.
  • The study's lead author, M. Kato, is a researcher at the University of Bologna's Institute of Psychiatry.
  • The study was published in the American Journal of Medical Genetics Part B - Neuropsychiatric Genetics.

Statistics:

  • 137 Japanese patients with major depressive disorder were followed for 6 weeks.
  • The study found a significant association between the rs10042486C/T variant and improved antidepressant response (P-value not provided).
  • The researchers observed a strong linkage disequilibrium between the rs10042486C/G, rs6295C/G, and rs1364043T/G variants.
  • The study's results must be verified on larger samples.

Sources:

  • Kato, M., et al. "Effect of 5-HT1A Gene Polymorphisms on Antidepressant Response in Major Depressive Disorder." American Journal of Medical Genetics Part B - Neuropsychiatric Genetics, vol. 150B, no. 1, 2009, pp. 115-123.
  • University of Bologna, Institute of Psychiatry, Viale Carlo Pepoli 5, I-40123 Bologna, Italy.
  • M. Kato, University of Bologna, Institute Psychiatry, Viale Carlo Pepoli 5, I-40123 Bologna, Italy.
  • American Journal of Medical Genetics Part B - Neuropsychiatric Genetics, Wiley-Liss, Division John Wiley & Sons Inc., 111 River St., Hoboken, NJ 07030, USA.